Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Gene therapy: current status and promise].

Y Kaneda1

  • 1Division of Gene Therapy Science, Graduate School of Medicine, Osaka University, Suita, Osaka 565-0871, Japan. kaneday@gts.med.osaka-u.ac.jp

Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica
|May 8, 2001
PubMed
Summary

Human gene therapy shows promise for diseases like SCID-X1, but effective gene delivery systems are crucial. Overcoming cellular barriers and improving vector systems are key challenges for successful in vivo gene transfer.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Suppressive effects of 1,4-dihydroxy-2-naphthoic acid administration on bone resorption.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2009
Same author

7.6 W of continuous-wave radiation in a TEM(00) mode from a laser-diode end-pumped Nd:YAG laser.

Optics letters·2009
Same author

Highly efficient eradication of intracranial glioblastoma using Eg5 siRNA combined with HVJ envelope.

Gene therapy·2009
Same author

Ex vivo transfer of nuclear factor-kappaB decoy ameliorates hepatic cold ischemia/reperfusion injury.

Transplantation proceedings·2009
Same author

Development of boron nanocapsules for neutron capture therapy.

Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine·2009
Same author

Expression of human beta-defensin -1, -2, and -3 in non-inflamed pseudocyst, mucoceles.

Oral diseases·2008

Area of Science:

  • Biotechnology
  • Molecular Biology
  • Genetics

Context:

  • Over 400 human gene therapy protocols reported by summer 2000.
  • Successful applications noted in arteriosclerosis obliterance, severe combined immunodeficiency X-1 (SCID-X1), and hemophilia B.
  • Complications have occurred, highlighting the need for improved safety and efficacy.

Purpose:

  • To review the status of human gene therapy protocols.
  • To identify challenges in gene delivery systems for in vivo gene transfer.
  • To discuss the barriers affecting gene transfection in tissues and propose solutions.
  • To emphasize the need for social system preparation for clinical trials in Japan.

Summary:

  • Gene therapy success hinges on effective gene delivery systems.
  • Chimeric vector systems combining multiple vectors are under development but imperfect.
  • In vivo gene transfer faces difficulties due to cellular resistance and functional interference.
  • Reevaluating tissue barriers and developing solutions are essential for advancing gene therapy.

Impact:

  • Highlights the critical role of vector systems in gene therapy efficacy.
  • Identifies key biological and technical hurdles in current gene therapy approaches.
  • Stresses the importance of interdisciplinary research and infrastructure development for clinical translation.

Related Experiment Videos